Companies › Eli Lilly › Total assets
Eli Lilly total assets, 2008–2025
Eli Lilly reported total assets of $112.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 42.9% from $78.7 billion the year before, according to its Form 10-K.
Fiscal years labeled by the year in which they ended. Bars drawn from the table below.
Eli Lilly total assets by fiscal year
| Fiscal year ended | Total assets | Change | Filing |
|---|---|---|---|
| Dec. 31, 2025 | $112.5B | +42.9% | 10-K (2026) ↗ |
| Dec. 31, 2024 | $78.7B | +23.0% | 10-K (2026) ↗ |
| Dec. 31, 2023 | $64.0B | +29.3% | 10-K (2025) ↗ |
| Dec. 31, 2022 | $49.5B | +1.4% | 10-K (2024) ↗ |
| Dec. 31, 2021 | $48.8B | +4.7% | 10-K (2023) ↗ |
| Dec. 31, 2020 | $46.6B | +18.7% | 10-K (2022) ↗ |
| Dec. 31, 2019 | $39.3B | −10.5% | 10-K (2021) ↗ |
| Dec. 31, 2018 | $43.9B | −2.4% | 10-K (2020) ↗ |
| Dec. 31, 2017 | $45.0B | +15.9% | 10-K (2019) ↗ |
| Dec. 31, 2016 | $38.8B | +9.1% | 10-K (2018) ↗ |
| Dec. 31, 2015 | $35.6B | −2.0% | 10-K (2017) ↗ |
| Dec. 31, 2014 | $36.3B | +3.0% | 10-K (2016) ↗ |
| Dec. 31, 2013 | $35.2B | +2.5% | 10-K (2015) ↗ |
| Dec. 31, 2012 | $34.4B | +2.2% | 10-K (2014) ↗ |
| Dec. 31, 2011 | $33.7B | +8.6% | 10-K (2013) ↗ |
| Dec. 31, 2010 | $31.0B | +12.9% | 10-K (2012) ↗ |
| Dec. 31, 2009 | $27.5B | −6.0% | 10-K (2011) ↗ |
| Dec. 31, 2008 | $29.2B | — | 10-K (2010) ↗ |
Other Eli Lilly financials
RevenueNet incomeDiluted EPSR&D expenseOperating cash flowDividends per shareDiluted sharesCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub
FAQ
Q What was Eli Lilly's total assets in its latest fiscal year?
A Eli Lilly reported total assets of $112.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 42.9% from $78.7 billion the year before, according to its Form 10-K.
Q What is Eli Lilly's highest annual total assets on record here?
A $112.5 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.
Q Where does this total assets data come from?
A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Total assets on the balance sheet at fiscal year-end.
Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Total assets on the balance sheet at fiscal year-end. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.